FDA Approves Supernus Pharmaceuticals’ Onapgo for Managing Motor Fluctuations in Parkinson Disease
Approval of Onapgo (apomorphine hydrochloride) marks the first and only subcutaneous apomorphine infusion device for managing ...
Legos holds a PhD in physiology from Temple University and an MBA in finance from Villanova University. He has also written ...
Dan Rizzo, global head of Veeva Business Consulting, spoke with Pharmaceutical Executive about the state of product launches ...
Biljana Naumovic discusses the importance of finding ways to reach out to underserved communites.
In this Pharmaceutical Executive video interview, Edoardo Madussi, Head of Business Development, Intelligencia AI discusses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results